Delcath Systems, Inc.
NASDAQ:DCTHMedical - Devices
-$0.23 today
- Market cap
- $685.32M
- Beta
- 0.52
- P/E (TTM)
- 751.4
- EPS (TTM)
- $0.02
Volume 0.59M
Average 0.42M
DCTH EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Delcath Systems, Inc.NASDAQ: DCTH
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) turns negative
Q1 FY2026 EPS (Basic) was -$0.03, compared with $0.03 a year earlier. Trailing-twelve-month EPS (Basic) was $0.02.
Context
- EPS (Basic) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 3 analysts of $0.18 (+134.5%) for the fiscal year ending Dec 2026, a step up from the +108.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.03+42.9% QoQ
- Last fiscal yearDec 2025
- $0.08+108.1% YoY
- LTMMar 2026
- $0.02+103.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -196.1% | -218.2% | -22.1 pp |
| 1 year | +108.1% | +134.5% | +26.3 pp |
| 3-year CAGR | — | +78.4% | — |
| 5-year CAGR | +71.8% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- 0.08 USD
- Year-over-year change
- +108.1%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.08 | +108.1% |
| FY2024 | 2024-12-31 | (0.93) | +68.5% |
| FY2023 | 2023-12-31 | (2.94) | +28.7% |
| FY2022 | 2022-12-31 | (4.12) | -14.7% |
| FY2021 | 2021-12-31 | (3.59) | — |
EPS (Basic) vs competitors
How DCTH compares with its peers on the latest reported figures
- DCTH's LTM Mar 2026 EPS (Basic) of $0.02 is the highest of the 4 companies compared; the peer median is -$1.53.
- Its year-over-year change of +103.3% is the highest of 4, against a peer median of -24.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $0.02 | +103.3% | — | |
| LTM Mar 2026 | -$1.41 | -24.8% | — | |
| LTM Mar 2026 | -$1.53 | -1.3% | — | |
| LTM Mar 2026 | -$26.44 | -2085.1% | — | |
| Peer median (excluding DCTH) | -$1.53 | -24.8% | — | |
Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.56M | 2.72M | 2.07M | 37.21M | 85.23M |
| Cost of Revenue | 671K | 686K | 635K | 6.19M | 11.8M |
| Gross Profit | 2.88M | 2.03M | 1.43M | 31.02M | 73.43M |
| Gross Margin | 81.1% | 74.8% | 69.2% | 83.4% | 86.2% |
| Research & Development | 13.78M | 18.58M | 17.5M | 13.87M | 29.25M |
| Selling, General & Admin | 13.64M | 17.3M | 22.11M | 29.55M | 43.53M |
| Operating Expenses | 27.42M | 35.89M | 39.61M | 43.43M | 72.77M |
| Depreciation & Amortization | 146K | 132K | 399K | 229K | 349K |
| EBITDA | (24.32M) | (33.69M) | (45.84M) | (26.16M) | 3.86M |
| EBITDA Margin | -684.0% | -1239.1% | -2219.9% | -70.3% | 4.5% |
| Operating Income | (24.53M) | (33.85M) | (38.18M) | (12.41M) | 660K |
| Operating Margin | -690.0% | -1245.1% | -1849.0% | -33.4% | 0.8% |
| Interest Income | 0 | 0 | 0 | 125K | 2.92M |
| Interest Expense | 1.19M | 2.69M | 1.44M | 0 | 0 |
| Other Income / Expenses | (1.12M) | (2.66M) | (9.5M) | (13.98M) | 2.85M |
| Income Before Tax | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 3.51M |
| Pre-Tax Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 4.1% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 810K |
| Net Income | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 2.7M |
| Net Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 3.2% |
| EPS (Basic) | (3.59) | (4.12) | (2.94) | (0.93) | 0.08 |
| EPS (Diluted) | (3.59) | (4.12) | (2.94) | (0.93) | 0.07 |
| Weighted Avg Shares | 7.15M | 8.86M | 16.23M | 28.51M | 35.82M |
| Weighted Avg Shares (Diluted) | 7.15M | 8.86M | 16.23M | 28.51M | 39.92M |
Delcath Systems, Inc.
NASDAQ:DCTH
Intrinsic Alpha fair value
Locked
Current Price
$19.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.